Evidence map›Paper›PMID 36869774›Full record

ArticleCardiovascular research2023

Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.

Florian Funk, Annette Kronenbitter, Katarzyna Hackert, Matthias Oebbeke, Gerhard Klebe, Mareike Barth, Daniel Koch, Joachim P Schmitt

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Tegaserod Stimulates 5-HTInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Florian FunkInstitute of Pharmacology, University Hospital Düsseldorf, and Cardiovascular Research Institute Düsseldorf (CARID), Heinrich-Heine-University, Universitätsstraße 1, 40225 Düsseldorf, Germany.
Annette KronenbitterInstitute of Pharmacology, University Hospital Düsseldorf, and Cardiovascular Research Institute Düsseldorf (CARID), Heinrich-Heine-University, Universitätsstraße 1, 40225 Düsseldorf, Germany.
Katarzyna HackertInstitute of Pharmacology, University Hospital Düsseldorf, and Cardiovascular Research Institute Düsseldorf (CARID), Heinrich-Heine-University, Universitätsstraße 1, 40225 Düsseldorf, Germany.
Matthias OebbekeInstitute of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany.
Gerhard KlebeInstitute of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany.
Mareike BarthDepartment of Cardiovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany.
Daniel KochMax Planck Institute for Neurobiology of Behavior-caesar, Cellular computations and learning group, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany.
Joachim P SchmittInstitute of Pharmacology, University Hospital Düsseldorf, and Cardiovascular Research Institute Düsseldorf (CARID), Heinrich-Heine-University, Universitätsstraße 1, 40225 Düsseldorf, Germany.ORCID 0000-0001-5742-1680
Düsseldorf University Hospital · DEPhilipps University of Marburg · DEMax Planck Institute for Neurobiology of Behavior – caesar · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsA key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. METHODS AND

resultsWe generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca2+ cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca2+ cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis.

conclusionsThe findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload.

Indexed as

CalciumSarcoplasmic Reticulum Calcium-Transporting ATPasesAdrenergic AgentsAnimalsCalcium-Binding ProteinsCyclic AMP-Dependent Protein KinasesMiceMice, TransgenicMyocytes, CardiacPhospholambanPhosphorylationSarcoplasmic ReticulumAdrenergic AgentsCalciumCalcium-Binding ProteinsCyclic AMP-Dependent Protein KinasesPhospholambanSarcoplasmic Reticulum Calcium-Transporting ATPasesCardiomyocyte calcium cyclingProtein kinase ASarcomere functionSERCA2a/phospholamban complexVentricular pressure overload

Identifiers

PMID36869774
PMCPMC10318394
OpenAlexW4323067023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.